Sakarya Universitesi Egitim ve Arastirma Hastanesi

Sakarya 54100

1 studies enrolling now · 2 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, COVID-19, SARS-CoV-2 Infection

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed